C07C 219/34
Compounds containing amino and esterified hydroxy groups bound to the same carbon
Official title: having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
C07C219/34 (Compounds containing amino and esterified hydroxy groups bound to the same carbon) appears on 89 US grants and 70 published applications in this corpus.
Search patents in C07C- Granted patents
- 89
- Published applications
- 70
- Assignees
- 47
- Inventors
- 204
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 12 | 5 |
| 2003 | 3 | 12 |
| 2004 | 13 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 3 |
| 2009 | 2 | 4 |
| 2010 | 0 | 2 |
| 2011 | 3 | 3 |
| 2012 | 4 | 3 |
| 2013 | 2 | 3 |
| 2014 | 6 | 6 |
| 2015 | 3 | 6 |
| 2016 | 1 | 5 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 5 |
| 2021 | 4 | 2 |
| 2022 | 3 | 0 |
| 2023 | 1 | 1 |
| 2024 | 3 | 2 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Second generation GRP94-selective inhibitors8 Apr 2025US 12,269,798 B2University of Kansas
- Monomer and polymer, compensation film, optical film, and display device16 Jul 2024US 12,037,304 B2Samsung Electronics Co., Ltd.
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator2 Jul 2024US 12,024,491 B2Vertex Pharmaceuticals Incorporated
- Application of the ionic iron (III) complex as catalyst in preparation of benzylamine compound6 Feb 2024US 11,890,602 B2Soochow University
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator25 Jul 2023US 11,708,331 B2Vertex Pharmaceuticals Incorporated
- Substituted 3-fluorobenzenepropanoate compound and preparation method therefor, pharmaceutical composition thereof, and use thereof14 May 2026US 2026/0132115 A1Tianjin Gudui Bio-Pharm Co., Ltd.
- Second generation grp94-selective inhibitors14 Aug 2025US 2025/0257027 A1University of Kansas
- Novel compound for degradation of target protein or polypeptide by polyubiquitination26 Dec 2024US 2024/0425517 A1Prazer Therapeutics Inc.
- Processes for making modulators of cystic fibrosis transmembrane conductance regulator23 May 2024US 2024/0166607 A1Vertex Pharmaceuticals Incorporated
- Monomer and polymer, compensation film, optical film, and display device22 Jun 2023US 2023/0192592 A1Samsung Electronics Co., Ltd.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Modulators of ATP-binding cassette transporters97US 8,324,242 B2Vertex Pharmaceutical Incorporated · 2012
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Modulators of ATP-binding cassette transporters74US 8,629,162 B2Vertex Pharmaceuticals Incorporated · 2014